Effect of a free radical scavenger, edaravone, in the treatment of patients with aneurysmal subarachnoid hemorrhage

scientific article published in March 2009

Effect of a free radical scavenger, edaravone, in the treatment of patients with aneurysmal subarachnoid hemorrhage is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1227/01.NEU.0000338067.83059.EB
P698PubMed publication ID19240603

P50authorMasato NaraokaQ42362440
P2093author name stringNorihito Shimamura
Hiroki Ohkuma
Takahiro Nakano
Akira Munakata
Kenichirou Asano
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectedaravoneQ335099
P304page(s)423-8; discussion 428-9
P577publication date2009-03-01
P1433published inNeurosurgeryQ7002693
P1476titleEffect of a free radical scavenger, edaravone, in the treatment of patients with aneurysmal subarachnoid hemorrhage
P478volume64

Reverse relations

cites work (P2860)
Q35088321A proposed definition of symptomatic vasospasm based on treatment of cerebral vasospasm after subarachnoid hemorrhage in Japan: Consensus 2009, a project of the 25 Spasm Symposium
Q48308572Advances in Treatment of Cerebral Vasospasm: an Update
Q43262774Alpha lipoic acid alleviates oxidative stress and preserves blood brain permeability in rats with subarachnoid hemorrhage
Q36711857Clinical trials in cardiac arrest and subarachnoid hemorrhage: lessons from the past and ideas for the future
Q48234772Edaravone attenuates intracerebroventricular streptozotocin-induced cognitive impairment in rats.
Q92308846Edaravone combined with cinepazide maleate on neurocyte autophagy and neurological function in rats with subarachnoid hemorrhage
Q27335848Edaravone guards dopamine neurons in a rotenone model for Parkinson's disease
Q40898682Edaravone offers neuroprotection for acute diabetic stroke patients
Q47376779Edaravone reduces astrogliosis and apoptosis in young rats with kaolin-induced hydrocephalus
Q93170488Effect of L-Arginine Therapy on Vasospasm: Experimental Study in Rats
Q34456056Effect of edaravone on radiation-induced brain necrosis in patients with nasopharyngeal carcinoma after radiotherapy: a randomized controlled trial
Q91762699Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and older
Q26748764Intracerebral Hemorrhage, Oxidative Stress, and Antioxidant Therapy
Q36831190Medical Management of Cerebral Vasospasm following Aneurysmal Subarachnoid Hemorrhage: A Review of Current and Emerging Therapeutic Interventions
Q34504672Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury
Q40050004Neuroprotective effect of edaravone in experimental glaucoma model in rats: a immunofluorescence and biochemical analysis
Q38170048Phenotypic transformation of smooth muscle in vasospasm after aneurysmal subarachnoid hemorrhage
Q43079903Potential of edaravone for neuroprotection in neurologic diseases that do not involve cerebral infarction.
Q39663927Statins and anti-inflammatory therapies for subarachnoid hemorrhage.
Q38213375The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage.
Q58920601Therapeutic time window for edaravone treatment of traumatic brain injury in mice
Q33747387To look beyond vasospasm in aneurysmal subarachnoid haemorrhage.
Q36230958Treatment of cerebral vasospasm following aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis
Q34095042Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature

Search more.